![These highlights do not include all the information needed to use TOBRAMYCIN INHALATION SOLUTION safely and effectively. See full prescribing information for TOBRAMYCIN INHALATION SOLUTION. TOBRAMYCIN INHALATION solution, for oral inhalation use These highlights do not include all the information needed to use TOBRAMYCIN INHALATION SOLUTION safely and effectively. See full prescribing information for TOBRAMYCIN INHALATION SOLUTION. TOBRAMYCIN INHALATION solution, for oral inhalation use](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=pouch.jpg&id=706575)
These highlights do not include all the information needed to use TOBRAMYCIN INHALATION SOLUTION safely and effectively. See full prescribing information for TOBRAMYCIN INHALATION SOLUTION. TOBRAMYCIN INHALATION solution, for oral inhalation use
![Tobramycin In 0.225 % Sodium Chloride Inhalation: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD Tobramycin In 0.225 % Sodium Chloride Inhalation: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD](https://img.medscapestatic.com/pi/features/drugdirectory/octupdate/TEV40851.jpg)
Tobramycin In 0.225 % Sodium Chloride Inhalation: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
![Tobramycin by Amneal Pharmaceuticals LLC / Amneal Pharmaceuticals, LLC / Catalent Pharma Solutions, LLC TOBRAMYCIN solution Tobramycin by Amneal Pharmaceuticals LLC / Amneal Pharmaceuticals, LLC / Catalent Pharma Solutions, LLC TOBRAMYCIN solution](https://fda.report/DailyMed/15f9c0cd-7dbf-4a91-9961-14f1dd000343/tobramycin-inhalation-solution-usp-23.jpg)
Tobramycin by Amneal Pharmaceuticals LLC / Amneal Pharmaceuticals, LLC / Catalent Pharma Solutions, LLC TOBRAMYCIN solution
![The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol - The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol -](https://ars.els-cdn.com/content/image/1-s2.0-S2451865422001624-gr2.jpg)